In a follow-up study, melanoma EVs isolated from plasma of melanoma patients again consistently contained FasL as well as TRAIL, and FasL-blocking antibodies partially reduced EV-induced T cell apoptosis in vitro (15). This evidence concerns the gene FASLG and melanoma.